Compare SII & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SII | VCYT |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2011 | 2013 |
| Metric | SII | VCYT |
|---|---|---|
| Price | $103.31 | $57.13 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $132.00 | $44.00 |
| AVG Volume (30 Days) | 191.4K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $26.03 | $13.76 |
| Revenue Next Year | $11.83 | $12.35 |
| P/E Ratio | ★ $63.42 | $162.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.94 | $22.61 |
| 52 Week High | $169.63 | $60.91 |
| Indicator | SII | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 34.92 | 59.92 |
| Support Level | $103.64 | $40.27 |
| Resistance Level | $152.45 | $60.91 |
| Average True Range (ATR) | 4.87 | 2.85 |
| MACD | -0.32 | -0.50 |
| Stochastic Oscillator | 9.12 | 59.32 |
Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).